GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Trials & Approvals AKCEA-APOCIII-LRx
Ionis Initiates Phase 3 Trials for Familial Chylomicronemia Syndrome Treatment
2020-12-06
Trials & Approvals
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
Trials & Approvals
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
Trials & Approvals Pyruvate Kinase Deficiency
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
Trials & Approvals Vaccine
Moderna Files for USFDA Authorization After Achieving 94.1% Vaccine Efficacy
2020-11-30
Trials & Approvals Cystic Fibrosis
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
Trials & Approvals
Ascentage Pharma’s Bcl-2 Inhibitor Enters Clinical Trials in Europe
2020-11-28
Trials & Approvals
FDA Requests Additional Info for Liquidia’s Pulmonary Arterial Hypertension Treatment
2020-11-27
Trials & Approvals Influenza
Xofluza Garners FDA Approval for Influenza Prevention Following Contact with Infected Patients
2020-11-26
Trials & Approvals Liver Enzyme
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
COVID-19 Antibody Cocktail
COVID-19: After Lilly, Regeneron Bags EUA for its Antibody Therapy
2020-11-24
Trials & Approvals Blood Clotting
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
COVID-19 Stem Cell Therapy
Novartis Secures Exclusive Rights of Mesoblast’s Cell Therapy for COVID-19 Related ARDS
2020-11-21
1 … 35 36 37 38 39 … 50
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top